Runnymede Capital Advisors »

iShares Dow Jones US Pharm Indx shares owned by Runnymede Capital Advisors

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Runnymede Capital Advisors from 13F filings

Historical chart of Runnymede Capital Advisors investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Runnymede Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Runnymede Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $200k 2.3k 86.68
2025-03-31 $167k 2.4k 70.56

More positions owned by Runnymede Capital Advisors

Proshares Ultra Technology Uit Exchange Traded (ROM)
Invesco Qqq Tr Uit Exchange Traded (QQQ)
Micron Technology Common Stock (MU)
Nvidia Corp Common Stock (NVDA)
Alphabet Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Ishares U.s. Technology Etf Uit Exchange Traded (IYW)
Lam Resh Corp Common Stock (LRCX)
Ishares S&p 100 Etf Uit Exchange Traded (OEF)
Marathon Pete Corp Common Stock (MPC)
Palo Alto Networks Common Stock (PANW)
Blackstone Common Stock (BX)
Alphabet Common Stock (GOOG)

View all positions for Runnymede Capital Advisors

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Foundations Investment Advisors
Morgan Stanley
Bank of America Corporation
Aptus Capital Advisors
McElhenny Sheffield Capital Management
LPL Financial
Anfield Capital Management
Insight Wealth Strategies
Royal Bank of Canada
Cetera Investment Advisers
Prevail Innovative Wealth Advisors
Goldman Sachs Group
Virtue Capital Management
Brown Advisory Holdings Incorporated

View all funds holding iShares Dow Jones US Pharm Indx